Galera Therapeutics, Inc.
OBX-115
melanoma
Resolved
7days ago
Phase 2 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 2 trial results for OBX-115 in melanoma are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 16h ago
“Melanoma RP2D data 1H 2026”